Anti-biofilm and antibacterial activities of zinc oxide nanoparticles against the oral opportunistic pathogens Rothia dentocariosa and Rothia mucilaginosa

European Journal of Oral Sciences

Volumn 122, Issue 6, 2014, Pages 397-403

  Khan, Shams T ^a   Ahamed, Maqusood ^b   Musarrat, Javed ^c   Al Khedhairy, Abdulaziz A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Anti biofilm activity; Antimicrobial activity; Rothia sp.; Zinc oxide nanoparticles

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; ANTIINFECTIVE AGENT; BACTERIAL RNA; COLORING AGENT; CRYSTAL VIOLET; FLUORESCENT DYE; INDOLE DERIVATIVE; METAL NANOPARTICLE; POLYSTYRENE DERIVATIVE; PROPIDIUM IODIDE; RNA 16S; ZINC OXIDE;

ACTINOMYCETACEAE; ADULT; BACTERIAL LOAD; BIOFILM; CLASSIFICATION; DIAGNOSTIC USE; DRUG EFFECTS; HUMAN; MALE; MATERIALS TESTING; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MOUTH; PHYLOGENY; TOOTH PROSTHESIS;

ACTINOMYCETACEAE; ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL LOAD; BACTERIOLOGICAL TECHNIQUES; BIOFILMS; COLORING AGENTS; DENTAL PROSTHESIS; FLUORESCENT DYES; GENTIAN VIOLET; HUMANS; INDOLES; MALE; MATERIALS TESTING; METAL NANOPARTICLES; MOUTH; PHYLOGENY; POLYSTYRENES; PROPIDIUM; RNA, BACTERIAL; RNA, RIBOSOMAL, 16S; TOOTH, ARTIFICIAL; ZINC OXIDE;

EID: 84931568929     PISSN: 09098836     EISSN: 16000722     Source Type: Journal    
DOI: 10.1111/eos.12152     Document Type: Article

References (44)

1. Ruoff K. Miscellaneous catalase-negative, gram-positive cocci: emerging opportunists. J Clin Microbiol 2002; 40: 1129-1133.
2. Boudewijns M, Magerman K, Verhaegen J, Debrock G, Peetermans WE, Donkersloot P, Mewis A, Peeters V, Rummens JL, Cartuyvels R. Rothia dentocariosa, endocarditis and mycotic aneurysms: case report and review of the literature. Clin Microbiol Infect 2003; 9: 222-229.
3. Schiff MJ, Kaplan MH. Rothia dentocariosa pneumonia in an immunocompromised patient. Lung 1987; 165: 279-282.
4. Ricaurte JC, Klein O, Labombardi V, Martinez V, Serpe A, Joy M. Rothia dentocariosa endocarditis complicated by multiple intracranial hemorrhages. South Med J 2001; 94: 438-440.
5. Collins MD, Hutson RA, Baverud V, Falsen E. Characterization of a Rothia-like organism from a mouse: description of Rothia nasimurium sp. nov. and reclassification of Stomatococcus mucilaginosus as Rothia mucilaginosa comb. nov. Int J Syst Evol Microbiol 2000; 50: 1247-1251.
6. Vaccher S, Cordiali R, Osimani P, Manso E, de-Benedictis FM. Bacteremia caused by Rothia mucilaginosa in a patient with Shwachman-Diamond syndrome. Infection 2007; 35: 209-210.
7. Fusconi M, Conti C, De Virgilo A, de Vincentiis M. Paucisymptomatic pneumonia due to Rothia mucilaginosa: case report and literature review. Le Infezioni Medicina 2009; 17: 100-104.
8. Chavan RS, Pannaraj PS, Luna RA, Szabo S, Adesina A, Versalovic J. Significant morbidity and mortality attributable to Rothia mucilaginosa infections in children with hematological malignancies or following hematopoietic stem cell transplantation. J Pediatr Hematol Oncol 2013; 30: 445-454.
9. Michon J, Jeulin D, Lang JM, Cattoir V. Rothia aeria acute bronchitis: the first reported case. Infection 2010; 38: 335-337.
10. Monju A, Shimizu N, Yamamoto M, Oda K, Kawamoto Y, Ohkusu K. First case report of sepsis due to Rothia aeria in a neonate. J Clin Microbiol 2009; 47: 1605-1606.
11. Gruson D, Hilbert G, Pigneux A, Vargas F, Guisset O, Texier J, Boiron JM, Reiffers J, Gbikpi-Benissan G, Cardinaud JP. Severe infection caused by Stomatococcus mucilaginosus in a neutropenic patient: case report and review of the literature. Hematol Cell Ther 1998; 40: 167-169.
12. Pérez-Vega C, Narváez J, Calvo G, Castro-Bohorquez FJ, Falgueras MT, Vilaseca-Momplet J. Cerebral mycotic aneurysm complicating Stomatococcus mucilaginosus infective endocarditis. Scand J Infect Dis 2002; 34: 863-866.
13. Sweeney LC, Dave J, Chambers PA, Heritage J. Antibiotic resistance in general dental practice-a cause for concern? J Antimicrob Chemother 2004; 4: 567-576.
14. Khan ST, Ahamed M, Al-Khedhairy AA, Musarrat J. Biocidal effect of copper and zinc oxide nanoparticles on human oral microbiome and biofilm formation. Mater Lett 2013a; 97: 67-70.
15. 2, Ni- and NiO-NPs in controlling oral bacterial growth and biofilm formation on oral surfaces. Arch Oral Biol 2013b; 58: 1804-1811.
16. Hajipour MJ, Fromm KM, Ashkarran AA, Jimenez de Aberasturi D, de Larramendi IR, Rojo T, Serpooshan V, Parak WJ, Mahmoudi M. Antibacterial properties of nanoparticles. Trends Biotechnol 2012; 90: 499-511.
17. Huh AJ, Kwon YJ. "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J Controlled Release 2011; 156: 128-145.
18. Takatsuka T, Tanaka K, Iijima Y. Inhibition of dentine demineralization by zinc oxide: in vitro and in situ studies. Dent Mater 2005; 21: 1170-1177.
19. Daneshvar MI, Hollis DG, Weyant RS, Jordan JG, Macgregor JP, Morey RE, Whitney AM, Brenner DJ, Steigerwalt AG, Helsel LO, Raney PM, Patel JB, Levett PN, Brown JM. Identification of some charcoal-black-pigmented CDC fermentative coryneform group 4 isolates as Rothia dentocariosa and some as Corynebacterium aurimucosum: proposal of Rothia dentocariosa emend. Georg and Brown 1967, Corynebacterium aurimucosum emend. Yassin et al. 2002, and Corynebacterium nigricans Shukla et al. 2003 pro synon. Corynebacterium aurimucosum. J Clin Microbiol 2004; 42: 4189-4198.
20. Ryu E. A simple method of differentiation between gram-positive and gram-negative organisms without staining. Kitasato Arch Exp Med 1940; 17: 58-63.
21. Cowan ST, Steel KJ. Manual for the identification of medical bacteria, 3rd edn. Cambridge: Cambridge University Press, 1993.
22. Khan ST, Nakagawa Y, Harayama S. Galbibacter mesophilus gen. nov., sp. nov., a novel member of the family Flavobacteriaceae. Int J Syst Evol Microbiol 2007; 57: 969-973.
23. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215: 403-410.
24. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997; 25: 4876-4882.
25. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987; 4: 406-425.
26. Schumann R, Schiewer U, Karsten U, Rieling T. Viability of bacteria from different aquatic habitats. II. Cellular fluorescent markers for membrane integrity and metabolic activity. Aquat Microb Ecol 2003; 32: 137-150.
27. Burton E, Yakandawala N, Lovetri K, Madhyastha MS. A microplate spectrofluorometric assay for bacterial biofilms. J Ind Microbiol Biotechnol 2007; 34: 1-4.
28. Yamane K, Nambu T, Yamanaka T, Mashimo C, Sugimori C, Leung K-P, Fukushima H. Complete genome sequence of Rothia mucilaginosa DY-18: a clinical isolate with dense meshwork-like structures from a persistent apical periodontitis lesion. Sequencing 2010; 2010. Article ID 457236.
29. Moon SE, Kim HY, Cha JD. Synergistic effect between clove oil and its major compounds and antibiotics against oral bacteria. Arch Oral Biol 2011; 56: 907-916.
30. Tarek N, Hassan HM, Abdelghani SMM, Radwan IA, Hammouda O, El-Gendy AO. Comparative chemical and antimicrobial study of nine essential oils obtained from medicinal plants growing in Egypt. Beni-Suef Univ J Basic Appl Sci 2014; 3: 149-156.
31. Fukui H, Horie M, Endoh S, Kato H, Fujita K, Nishio K, Komaba LK, Maru J, Miyauhi A, Nakamura A, Kinugasa S, Yoshida Y, Hagihara Y, Iwahashi H. Association of zinc ion release and oxidative stress induced by intratracheal instillation of ZnO nanoparticles to rat lung. Chem Biol Interact 2012; 198: 29-37.
32. Uda NR, Upert G, Angelici G, Nicolet S, Schmidt T, Schwede T, Creus M. Zinc-selective inhibition of the promiscuous bacterial amide-hydrolase DapE: implications of metal heterogeneity for evolution and antibiotic drug design. Metallomics 2013; 6: 88-95.
33. Kuznetsova SS, Azarkina NV, Vygodina TV, Siletsky SA, Konstantinov AA. Zinc ions as cytochrome c oxidase inhibitors: two sites of action. Biochemistry (Moscow) 2005; 70: 128-136.
34. Xie Y, He Y, Irwin LP, Jin T, Shi X. Antibacterial activity and mechanism of action of zinc oxide nanoparticles against Campylobacter jejuni. Appl Environ Microbiol 2011; 77: 2325-2331.
35. Hong T-K, Tripathy N, Son H-J, Ha K-T, Jeong H-S, Hahn YB. A comprehensive in vitro and in vivo study of ZnO nanoparticles toxicity. J Mater Chem 2013; 1: 2985-2992.
36. Beckett WS, Chalupa DF, Pauly-Brown A, Speers DM, Stewart JC, Frampton MW, Utell MJ, Huang L-S, Cox C, Zareba W, Oberdörster G. Comparing inhaled ultrafine versus fine zinc oxide particles in healthy adults: a human inhalation study. Am J Respir Crit Care Med 2005; 171: 1129-1135.
37. Musarrat J, Saquib Q, Azam A, Naqvi SAH. Zinc oxide nanoparticles-induced DNA damage in human lymphocytes. Int J Nanopart 2009; 2: 402-415.
38. 2 nanoparticles toward human lung epithelial cells. Sci Total Environ 2011; 409: 1219-1228.
39. Talebian N, Amininezhad SM, Doudi M. Controllable synthesis of ZnO nanoparticles and their morphology-dependent antibacterial and optical properties. J Photochem Photobiol, B 2013; 120: 66-73.
40. Eshed M, Lellouche J, Matalon S, Gedanken A, Banin E. Sonochemical coatings of ZnO and CuO nanoparticles inhibit Streptococcus mutans biofilm formation on teeth model. Langmuir 2012; 28: 12288-12295.
41. Liu Y, He L, Mustapha A, Li H, Hu ZQ, Lin M. Antibacterial activities of zinc oxide nanoparticles against Escherichia coli O157:H7. J Appl Microbiol 2009; 107: 1193-1201.
42. Sandstead HH. Requirements and toxicity of essential trace elements, illustrated by zinc and copper. Am J Clin Nutr 1995; 61 (Suppl): 621S-624S.
43. Zhou J, Xu N, Wang ZL. Dissolving behavior and stability of ZnO wires in biofluids: a study on biodegradability and biocompatibility of ZnO nanostructures. Adv Mater 2006; 18: 2432-2435.
44. Yu JX, Li TH. Distinct biological effects of different nanoparticles commonly used in cosmetics and medicine coatings. Cell Biosci 2011; 1: 19.